Listen to this downloadable audio from a live Webinar in which a rheumatology expert discusses the complexities of developing biosimilar products and making them available for patients with rheumatologic conditions.
In this downloadable slideset, William F. C. Rigby, MD, and Beth L. Jonas, MD, review key data to enhance your understanding of biosimilars and their clinical application to rheumatologic conditions.
What does the availability of biosimilar products mean in your approach to rheumatologic conditions?
What should you tell your rheumatology patients about biosimilars?
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.